Physician profile
Michael B Evans
NPI 1407897952
$1,492.14
in general payments reported to CMS, 2019-2025
9 companies · $547 in 2025
The $547 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.39 · 2021: $194 · 2022: $365 · 2023: $214 · 2024: $138 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.55 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $957.18 | 2021-2025 | Inspire |
| Integra Lifesciences Corporation | $173.62 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Genzyme Corporation | $143.91 | 2019-2025 | |
| Acclarent, INC | $79.24 | 2021-2023 | Relieva Spinplus |
| Aerin Medical INC. | $54.11 | 2022-2025 | |
| Amgen INC. | $34.00 | 2025 | |
| Stryker Corporation | $18.39 | 2022 | |
| Glaxosmithkline, LLC. | $18.35 | 2025 | Nucala |
| Merz North America, INC. | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.